Robbie Marcus
Stock Analyst at JP Morgan
(3.79)
# 694
Out of 5,241 analysts
188
Total ratings
52.46%
Success rate
7.58%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $340 → $275 | $147.46 | +86.49% | 6 | May 7, 2026 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $67 → $54 | $40.05 | +34.83% | 9 | May 5, 2026 | |
| SYK Stryker | Maintains: Overweight | $445 → $400 | $306.76 | +30.40% | 10 | May 1, 2026 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $95 → $77 | $61.31 | +25.59% | 2 | May 1, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $80 → $65 | $60.76 | +6.98% | 2 | Apr 30, 2026 | |
| CNMD CONMED | Maintains: Neutral | $43 → $40 | $35.49 | +12.71% | 9 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $100 → $95 | $83.70 | +13.50% | 8 | Apr 29, 2026 | |
| HTFL HeartFlow | Maintains: Overweight | $40 → $35 | $28.32 | +23.61% | 3 | Mar 19, 2026 | |
| MDT Medtronic | Maintains: Neutral | $105 → $100 | $76.15 | +31.32% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Overweight | $135 → $100 | $52.68 | +89.83% | 14 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $90 → $100 | $81.38 | +22.88% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $66 → $78 | $59.61 | +30.85% | 7 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $5.68 | +58.45% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $17 | $16.35 | +3.98% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $61.63 | +21.69% | 3 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $12 → $13 | $14.10 | -7.80% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $16.09 | -0.56% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $15.36 | +4.17% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $5.99 | +16.86% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $17.30 | +108.09% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $421.12 | +60.29% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $10.58 | +22.87% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $28.12 | +42.25% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $24.29 | +105.85% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $2.66 | +200.75% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $322.32 | -22.44% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $6.38 | +9.72% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $84.47 | +39.69% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $114.00 | +36.84% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $144.01 | -72.22% | 2 | May 5, 2020 |
Insulet
May 7, 2026
Maintains: Overweight
Price Target: $340 → $275
Current: $147.46
Upside: +86.49%
Inspire Medical Systems
May 5, 2026
Maintains: Neutral
Price Target: $67 → $54
Current: $40.05
Upside: +34.83%
Stryker
May 1, 2026
Maintains: Overweight
Price Target: $445 → $400
Current: $306.76
Upside: +30.40%
Merit Medical Systems
May 1, 2026
Maintains: Overweight
Price Target: $95 → $77
Current: $61.31
Upside: +25.59%
GE HealthCare Technologies
Apr 30, 2026
Maintains: Neutral
Price Target: $80 → $65
Current: $60.76
Upside: +6.98%
CONMED
Apr 30, 2026
Maintains: Neutral
Price Target: $43 → $40
Current: $35.49
Upside: +12.71%
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Neutral
Price Target: $100 → $95
Current: $83.70
Upside: +13.50%
HeartFlow
Mar 19, 2026
Maintains: Overweight
Price Target: $40 → $35
Current: $28.32
Upside: +23.61%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $105 → $100
Current: $76.15
Upside: +31.32%
Boston Scientific
Feb 5, 2026
Maintains: Overweight
Price Target: $135 → $100
Current: $52.68
Upside: +89.83%
Dec 18, 2025
Upgrades: Overweight
Price Target: $90 → $100
Current: $81.38
Upside: +22.88%
Dec 5, 2025
Maintains: Neutral
Price Target: $66 → $78
Current: $59.61
Upside: +30.85%
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $5.68
Upside: +58.45%
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $16.35
Upside: +3.98%
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $61.63
Upside: +21.69%
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $14.10
Upside: -7.80%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $16.09
Upside: -0.56%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $15.36
Upside: +4.17%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $5.99
Upside: +16.86%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $17.30
Upside: +108.09%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $421.12
Upside: +60.29%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $10.58
Upside: +22.87%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $28.12
Upside: +42.25%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $24.29
Upside: +105.85%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $2.66
Upside: +200.75%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $322.32
Upside: -22.44%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $6.38
Upside: +9.72%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $84.47
Upside: +39.69%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $114.00
Upside: +36.84%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $144.01
Upside: -72.22%